CNMD

CONMED Corporation

73.16

Top Statistics
Market Cap 2 B Forward PE 15.12 Revenue Growth 4.00 %
Current Ratio 2.27 Trailing PE 17.34 Earnings Growth 214.00 %
Profit Margins 10.23 % Peg Ratio Dividend Yield 1.09 %
Enterprice / EBITA 14.52 Enterprise / Revenue 2.46 Price To Sales Trailing12 Months 1.75
Profitability
Profit Margins 10.23 % Operating Margins 12.22 %
Balance Sheet
Total Cash 38 M Total Cash Per Share 1.25 Total Debt 940 M
Total Debt To Equity 100.85 Current Ratio 2.27 Book Value Per Share 30.21
All Measures
Short Ratio 530.00 % Message Board Id finmb_263232 Shares Short Prior Month 2 M
Return On Equity 0.1524 City Largo Uuid 92ab2efa-11d2-3920-97e3-c8c8bd3ed318
Previous Close 73.89 First Trade Date Epoch Utc 554 M Book Value 30.21
Beta 1.46 Total Debt 940 M Volume 288467
Price To Book 2.42 Last Split Date 1 B Fifty Two Week Low 61.05
Total Cash Per Share 1.25 Total Revenue 1 B Shares Short Previous Month Date 1 B
Target Median Price 80.00 Max Age 86400 Recommendation Mean 2.25
Sand P52 Week Change 0.3133 Operating Margins 12.22 % Last Dividend Value 0.2000
Target Mean Price 83.12 Net Income To Common 131 M Ask 78.00
Short Percent Of Float 0.1062 Implied Shares Outstanding 30 M Last Fiscal Year End 1 B
Trailing Peg Ratio None Average Daily Volume10 Day 383080 Average Volume10days 383080
Total Cash 38 M Next Fiscal Year End 1 B Revenue Per Share 41.82
Held Percent Insiders 0.0058 Ebitda Margins 16.91 % Dividend Rate 0.8000
Trailing PE 17.34 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 73.89 Target Low Price 72.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 69.51 Open 74.24 Dividend Yield 1.09 %
State FL Free Cashflow 126 M Return On Assets 0.0398
Time Zone Short Name EST Trailing Eps 4.22 Day Low 72.85
Address1 11311 Concept Boulevard Trailing Annual Dividend Rate 0.8000 Price Hint 2
Shares Outstanding 30 M Target High Price 102.00 Website https://www.conmed.com
52 Week Change -0.3180 Average Volume 419556 Earnings Quarterly Growth 209.30 %
Forward Eps 4.84 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 95.50 % Last Split Factor 3:2 Regular Market Day High 75.96
Is_sp_500 False Profit Margins 10.23 % Debt To Equity 100.85
Fifty Two Week High 117.27 Day High 75.96 Shares Short 2 M
Regular Market Open 74.24 Industry Key medical-devices Bid 72.93
Earnings Growth 214.00 % Enterprise To Revenue 2.46 Revenue Growth 4.00 %
Shares Percent Shares Out 0.0766 Operating Cashflow 180 M Five Year Avg Dividend Yield 82.00 %
Currency USD Market Cap 2 B Time Zone Full Name America/New_York
Is_nasdaq_100 False Zip 33773-4908 Payout Ratio 18.96 %
Quote Type EQUITY Industry Medical Devices Ex Dividend Date 1 B
Regular Market Day Low 72.85 Held Percent Institutions 1.14 Long Name CONMED Corporation
Current Price 73.16 Enterprise To Ebitda 14.52 Financial Currency USD
Trailing Annual Dividend Yield 1.08 % Current Ratio 2.27 Gross Margins 55.82 %
Industry Disp Medical Devices Number Of Analyst Opinions 8 Country United States
Float Shares 30 M Two Hundred Day Average 72.45 Enterprise Value 3 B
Price To Sales Trailing12 Months 1.75 Forward PE 15.12 Regular Market Volume 288467
Last Dividend Date 1 B Ebitda 217 M Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha
CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide.

The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as provides supporting products that enable surgeons to perform minimally invasive sports medicine surgeries.

It markets orthopedic surgery products under the Hall, CONMED Linvatec, Concept, and Shutt brands.

The company also provides battery-powered and autoclavable bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under Hall surgical brand name.

In addition, it offers general surgery products, including clinical insufflation systems under AirSeal brand; smoke removal devices under Buffalo Filter brand; endomechanical products, such as tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors used in minimally invasive surgeries; and electrosurgical solution comprising monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems and other accessories.

Further, the company provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products for the treatment of diseases of the dilatation, hemostasis, biliary, structure management, and infection prevention and patient monitoring, including ECG and EEG electrodes, and cardiac defibrillation pads.

It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors.

CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.